MGTX MeiraGTx Holdings plc - Ordinary Shares
NASDAQ · Biotechnology · 在 SEC EDGAR 上查看 ↗ 收盘 十月 2, 2026 10-K/10-Q 八月 13, 2026
$10.79
· % 处于52周区间
· 高于低点
· 至高点
$6.6252周低点
$15.3552周高点
市值 (MRQ)
$1.02B
P/E (TTM)
15.2
EPS (TTM)
$0.71
收入 (TTM)
$398M
MGTX 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$10.79
市值 (MRQ)
$1.02B
P/E (TTM)
15.2
EPS (TTM)
$0.71
收入 (TTM)
$398M
ROE (TTM)
72.2%
负债/权益
-4.3
52周区间
$7–$15
MGTX 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
区间
条形图
柱状图粒度会根据所选周期进行调整 — 将鼠标悬停在图表上可查看柱状图的开盘价/最高价/最低价/收盘价。
10年表现 收入、净利润、利润率和每股收益趋势
收入$81M2019-12-31 → 2025-12-31
EPS$-1.422020-12-31 → 2025-12-31
自由现金流$-50M2018-12-31 → 2025-12-31
净利率19.9%2019-12-31 → 2025-12-31
估值与比率
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
| 指标 | 5年趋势 | MGTX | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| P/E (TTM) | 15.25年均值 ≈-5.7 | ≈-5.7 | · | · | |
| P/S (TTM) | 2.65年均值 ≈20.4 | ≈20.4 | 8.0 | 低估 | |
| 市净率 (MRQ) | 4.75年均值 ≈-18.5 | ≈-18.5 | 4.2 | 估值过高 | |
| EV / EBITDA (企业价值 / EBITDA) | -9.0 | · | · | · | |
| 股价/自由现金流 (TTM) | 97.15年均值 ≈-8.4 | ≈-8.4 | · | · | |
| 市现率 (TTM) | 74.25年均值 ≈-25.5 | ≈-25.5 | · | · | |
| EV / Revenue (市值/营收) | 10.3 | · | · | · | |
| EV / FCF (市值/自由现金流) | -16.7 | · | · | · | |
| 市净率（有形资产） (MRQ) | 4.75年均值 ≈4.7 | ≈4.7 | · | · |
同行中位数按每项指标的标准化基础计算，可能与本股票显示的TTM/MRQ基础不完全匹配。
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
| 指标 | 5年趋势 | MGTX | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 营业利润率 (TTM) | 46.3%5年均值 ≈-387.2% | ≈-387.2% | -308.7% | 顶尖 | |
| 息税折旧摊销前利润率 (TTM) | 49.3%5年均值 ≈-354.8% | ≈-354.8% | -308.7% | 顶尖 | |
| Pretax Margin (税前利润率) | -140.3%5年均值 ≈-402.4% | ≈-402.4% | · | · | |
| 净利润率 (TTM) | 19.9%5年均值 ≈-402.4% | ≈-402.4% | -214.0% | 顶尖 | |
| ROA (TTM) | 26.5%5年均值 ≈-36.8% | ≈-36.8% | -37.2% | 弱 | |
| ROE (TTM) | 72.2%5年均值 ≈1531.6% | ≈1531.6% | -11.7% | 顶尖 | |
| ROIC | -562.0%5年均值 ≈-235.6% | ≈-235.6% | -165.3% | 弱 |
财务健康 债务、流动性、偿付能力 — 资产负债表强度
| 指标 | 5年趋势 | MGTX | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Debt / Equity (负债/股东权益比率) | -4.3 | · | · | · | |
| 流动比率 (MRQ) | 3.85年均值 ≈1.9 | ≈1.9 | 11.5 | 低流动性 | |
| Quick Ratio (速动比率) | 0.65年均值 ≈1.6 | ≈1.6 | 10.4 | 低流动性 | |
| Interest Coverage (利息保障倍数) | -8.75年均值 ≈-61.8 | ≈-61.8 | · | · |
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
| 指标 | 5年趋势 | MGTX | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Revenue YoY (营收同比增长) | 144.6%5年均值 ≈70.9% | ≈70.9% | · | · | |
| Revenue CAGR 3Y (营收3年复合年增长率) | 72.3%5年均值 ≈21.6% | ≈21.6% | · | · | |
| Revenue CAGR 5Y (营收5年复合年增长率) | 39.2% | · | · | · |
资本效率 资产周转率、库存周转率、应收账款周转率
| 指标 | 5年趋势 | MGTX | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Asset Turnover (资产周转率) | 0.35年均值 ≈0.1 | ≈0.1 | 0.2 | 顶尖 | |
| Receivables Turnover (应收账款周转率) | 43.9 | · | · | · | |
| Revenue / Employee (年营业收入 ÷ 员工人数（报告的 headcount，yfinance）。衍生数据 — 非存储的 SEC-XBRL 概念。) | ≈$207.1K | · | · | · |
价值 · ≈ 5年均值 · 行业中值 · 相对于中值的评判
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
77.7%
下次报告
十一月 11, 2026
| 期间 | 报告 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|---|
| 2026年6月30日 | 八月 13, 2026 | $1.71 | $-0.47 | 465.8% |
| 2026年3月31日 | 五月 14, 2026 | $-0.57 | $-0.41 | -39.2% |
| 2025年12月31日 | $0.19 | $-0.58 | 132.3% | |
| 2025年9月30日 | $-0.62 | $-0.50 | -24.0% | |
| 2025年6月30日 | $-0.48 | $-0.48 | -0.65% | |
| 2025年3月31日 | $-0.51 | $-0.50 | -2.7% | |
| 2024年12月31日 | $-0.50 | $-0.57 | 12.5% |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $81M | $33M | $14M | $16M | $38M | $16M | $13M | |
| R&D Expense | $130M | $119M | $104M | $86M | $67M | $34M | $25M | |
| SG&A Expense | $53M | $54M | $47M | $47M | $44M | $44M | $47M | |
| Operating Expenses | $187M | $197M | $151M | $132M | $110M | $78M | $72M | |
| Operating Income | $-106M | $-164M | $-137M | $-116M | $-73M | $-63M | $-58M | |
| Interest Expense | $12M | $13M | $13M | $5M | $288.0K | $139.0K | $48.6K | |
| Interest Income | $2M | $4M | $2M | $777.0K | $212.0K | $1M | $370.6K | |
| Pretax Income | $-114M | $-148M | $-84M | $-130M | $-80M | $-58M | $-55M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-114M | $-148M | $-84M | $-130M | $-80M | $-58M | $-55M | |
| EPS (Basic) | $-1.42 | $-2.12 | $-1.49 | $-2.87 | $-1.80 | $-1.54 | · | |
| EPS (Diluted) | $-1.42 | $-2.12 | $-1.49 | $-2.87 | $-1.80 | $-1.54 | · | |
| Shares (Basic) | 80,430,186 | 69,822,353 | 56,486,525 | 45,177,857 | 44,139,655 | 37,724,189 | · | |
| Shares (Diluted) | 80,430,186 | 69,822,353 | 56,486,525 | 45,177,857 | 44,139,655 | 37,724,189 | · | |
| EBITDA | $-93M | $-151M | $-123M | $-108M | $-65M | $-58M | $-58M |
资产负债表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $66M | $104M | $130M | $116M | $138M | $210M | $227M | |
| Receivables | $3M | $707.0K | $10M | $21M | · | · | · | |
| Inventory | · | $385.0K | · | · | · | · | · | |
| Prepaid Expense | $6M | $7M | $6M | $8M | $8M | $7M | $4M | |
| Other Current Assets | $2M | $2M | $1M | $2M | $2M | $5M | $2M | |
| Current Assets | $92M | $124M | $160M | $154M | $183M | $273M | $269M | |
| PP&E (Net) | $105M | $103M | $116M | $109M | $76M | $44M | $24M | |
| PP&E (Gross) | $158M | $145M | $149M | $130M | $90M | $52M | $28M | |
| Accum. Depreciation | $53M | $42M | $33M | $20M | $14M | $8M | $5M | |
| Intangibles | $578.0K | $821.0K | $1M | $1M | $2M | $2M | · | |
| Other Non-current Assets | $1M | $1M | $2M | $1M | $1M | $1M | $195.1K | |
| Total Assets | $244M | $270M | $327M | $318M | $320M | $364M | $324M | |
| Accounts Payable | $10M | $24M | $16M | $17M | $15M | $7M | $4M | |
| Accrued Liabilities | $33M | $27M | $43M | $40M | $28M | $21M | $18M | |
| Short-term Debt | $25M | · | · | · | · | · | · | |
| Current Liabilities | $123M | $61M | $67M | $82M | $68M | $54M | $49M | |
| Capital Leases | $11M | $8M | $13M | $17M | $20M | $20M | $22M | |
| Deferred Tax | · | · | · | $186.0K | $196.0K | $214.0K | $195.1K | |
| Total Liabilities | $250M | $202M | $189M | $200M | $135M | $125M | $133M | |
| Total Debt | $25M | · | · | · | · | · | · | |
| Common Stock | $3.0K | $3.0K | $2.0K | $2.0K | $2.0K | $2.0K | $1.4K | |
| Paid-in Capital | $808M | $774M | $694M | $582M | $529M | $504M | $396M | |
| Retained Earnings | $-816M | $-702M | $-554M | $-470M | $-341M | $-261M | $-203M | |
| AOCI | $2M | $-4M | $-1M | $6M | $-3M | $-5M | $-2M | |
| Stockholders' Equity | $-6M | $68M | $138M | $118M | $185M | $239M | $191M | |
| Liabilities + Equity | $244M | $270M | $327M | $318M | $320M | $364M | $324M | |
| Shares Outstanding | 81,120,931 | 78,397,380 | 63,601,015 | 48,477,209 | 44,548,925 | 44,189,150 | 36,791,906 |
现金流
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | $13M | $13M | $14M | $9M | $8M | $4M | $2M | |
| Stock-based Comp | $22M | $25M | $28M | $29M | $21M | $18M | $16M | |
| Deferred Tax | $-21M | $-24M | $-10M | $-26M | $-37M | $-16M | $-10M | |
| Amort. of Intangibles | · | · | · | $200.0K | $300.0K | $20.0K | $0 | |
| Other Non-cash | $54M | $29M | $-53M | $45M | $77M | $-13M | · | |
| Operating Cash Flow | $-46M | $-104M | $-105M | $-73M | $-11M | $-64M | $20M | |
| CapEx | $4M | $5M | $20M | $45M | $46M | $21M | $9M | |
| Investing Cash Flow | $-4M | $23M | $34M | $-45M | $-62M | $-37M | $-9M | |
| Stock Issued | $15M | $59M | $92M | $25M | · | $87M | $155M | |
| Net Stock Activity | $15M | $59M | $92M | · | · | $87M | $155M | |
| Financing Cash Flow | $12M | $55M | $84M | $95M | $2M | $83M | $148M | |
| Taxes Paid | $0 | $0 | · | · | · | · | · | |
| Free Cash Flow | $-50M | $-109M | $-126M | $-118M | $-57M | $-85M | $11M | |
| Levered FCF | $-62M | $-123M | · | $-123M | $-57M | $-85M | · |
盈利能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -130.2% | -493.4% | · | -730.9% | -194.1% | -401.9% | -438.4% | |
| Net Margin | -140.3% | -444.1% | · | -814.2% | -211.0% | -372.6% | -411.9% | |
| Pretax Margin | -140.3% | -444.1% | · | -814.2% | -211.0% | -372.6% | -411.9% | |
| EBITDA Margin | -114.8% | -454.9% | · | -676.1% | -173.3% | -375.1% | -438.4% | |
| ROA | -44.4% | -49.5% | -26.1% | -40.6% | -23.3% | -16.9% | -26.0% | |
| ROE | 8062.2% | -180.7% | -73.0% | -107.8% | -42.6% | -27.8% | -28.4% | |
| ROIC | -562.0% | -242.1% | · | -98.8% | -39.5% | -26.2% | · |
流动性与偿付能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.7 | 2.0 | 2.4 | 1.9 | 2.7 | 5.0 | 5.5 | |
| Quick Ratio | 0.6 | 1.7 | 2.1 | 1.4 | 2.0 | 3.9 | 4.6 | |
| Debt / Equity | -4.3 | · | · | · | · | · | · | |
| Interest Coverage | -8.7 | -12.4 | -10.3 | -23.5 | -254.1 | -449.4 | -1198.6 |
效率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.1 | · | 0.0 | 0.1 | 0.0 | 0.1 | |
| Receivables Turnover | 43.9 | 6.1 | · | · | · | · | · |
每股
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-0.07 | $0.87 | $2.17 | $2.43 | $4.16 | $5.40 | $5.19 | |
| Revenue / Share | $1.01 | $0.48 | · | $0.35 | $0.85 | · | · | |
| Cash Flow / Share | $-0.58 | $-1.50 | $-1.87 | $-1.62 | $-0.24 | · | · | |
| Cash / Share | $0.81 | $1.32 | $2.04 | $2.38 | $3.09 | $4.74 | $6.18 | |
| EPS (TTM) | $-1.42 | $-2.12 | $-1.49 | $-2.87 | $-1.80 | $-1.54 | · |
增长率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 144.6% | 137.4% | -11.9% | -57.8% | 142.2% | · | · | |
| Revenue CAGR 3Y | 72.3% | -4.1% | -3.4% | · | · | · | · | |
| Revenue CAGR 5Y | 39.2% | · | · | · | · | · | · |
估值 (TTM)
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $81M | $33M | $14M | $16M | $38M | $16M | $13M | |
| Net Income TTM | $-114M | $-148M | $-84M | $-130M | $-80M | $-58M | $-55M | |
| Market Cap | $645M | $477M | $446M | $316M | $1.06B | $669M | $737M | |
| Enterprise Value | $604M | · | · | · | · | · | · | |
| P/E | -5.6 | -2.9 | -4.7 | -2.3 | -13.2 | -9.8 | · | |
| P/S | 7.9 | 14.3 | 31.9 | 19.9 | 28.1 | 43.0 | 55.4 | |
| P/B | -111.3 | 7.0 | 3.2 | 2.7 | 5.7 | 2.8 | 3.9 | |
| P / Tangible Book | · | 7.1 | 3.3 | 2.7 | 5.8 | 2.8 | · | |
| P / Cash Flow | -13.9 | -4.6 | -4.2 | -4.3 | -100.4 | -10.5 | 36.7 | |
| P / FCF | -12.9 | -4.4 | -3.6 | -2.7 | -18.6 | -7.9 | 66.6 | |
| EV / EBITDA | -6.5 | · | · | · | · | · | · | |
| EV / FCF | -12.0 | · | · | · | · | · | · | |
| EV / Revenue | 7.4 | · | · | · | · | · | · | |
| Earnings Yield | -17.9% | -34.8% | -21.2% | -44.0% | -7.6% | -10.2% | · |
损益表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $321M | $293.0K | $75M | $410.0K | $4M | $2M | $21M | $11M | $282.0K | $697.0K | $2M | $5M | $4M | $3M | · | $5M | |
| R&D Expense | $58M | $32M | $31M | $33M | $33M | $33M | $24M | $26M | $35M | $34M | $34M | $28M | $20M | $22M | $22M | $17M | |
| SG&A Expense | $12M | $9M | $18M | $14M | $12M | $9M | $17M | $13M | $11M | $13M | $12M | $10M | $12M | $13M | $14M | $11M | |
| Operating Expenses | $77M | $41M | $49M | $46M | $48M | $44M | $53M | $51M | $46M | $47M | $46M | $38M | $32M | $35M | $36M | $28M | |
| Operating Income | $244M | $-41M | $26M | $-46M | $-45M | $-42M | $-31M | $-40M | $-46M | $-47M | $-44M | $-33M | $-29M | $-32M | $-41M | $-23M | |
| Interest Expense | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | |
| Interest Income | $706.0K | $189.0K | $278.0K | $161.0K | $408.0K | $971.0K | $1M | $1M | $827.0K | $1M | $549.0K | $523.0K | $655.0K | $545.0K | $432.0K | $288.0K | |
| Income Tax | $2M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | $0 | |
| Net Income | $161M | $-46M | $15M | $-51M | $-39M | $-40M | $-39M | $-39M | $-49M | $-20M | $20M | $-44M | $-30M | $-30M | $-27M | $-37M | |
| EPS (Basic) | $1.76 | $-0.57 | $0.19 | $-0.62 | $-0.48 | $-0.51 | $-0.49 | $-0.55 | $-0.76 | $-0.32 | $0.40 | $-0.74 | $-0.53 | $-0.62 | $-0.58 | $-0.83 | |
| EPS (Diluted) | $1.71 | $-0.57 | $0.19 | $-0.62 | $-0.48 | $-0.51 | $-0.49 | $-0.55 | $-0.76 | $-0.32 | $0.40 | $-0.74 | $-0.53 | $-0.62 | $-0.58 | $-0.83 | |
| Shares (Basic) | 91,418,527 | 81,300,944 | · | 80,947,703 | 80,585,625 | 79,032,341 | · | 71,633,150 | 64,376,396 | 64,065,895 | · | 59,526,642 | 55,349,534 | 48,638,151 | · | 44,687,635 | |
| Shares (Diluted) | 93,805,296 | 81,300,944 | · | 80,947,703 | 80,585,625 | 79,032,341 | · | 71,633,150 | 64,376,396 | 64,065,895 | · | 59,526,642 | 55,349,534 | 48,638,151 | · | 44,687,635 | |
| EBITDA | $244M | $-38M | · | $-43M | $-42M | $-39M | · | $-40M | $-46M | $-43M | · | $-33M | $-29M | $-29M | · | $-23M |
资产负债表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $143M | $72M | $66M | $15M | $32M | $67M | $104M | $123M | $100M | $119M | $130M | $63M | $93M | $69M | $116M | $115M | |
| Receivables | · | $3M | $3M | $3M | $2M | $734.0K | $707.0K | $3M | $2M | $11M | $10M | $22M | $33M | · | $21M | · | |
| Inventory | · | · | · | · | $314.0K | $607.0K | $385.0K | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $4M | $6M | $6M | $7M | $7M | $7M | $7M | $7M | $5M | $5M | $6M | $7M | $8M | $7M | $8M | $10M | |
| Other Current Assets | $27M | $670.0K | $2M | $328.0K | $780.0K | $606.0K | $2M | $713.0K | $660.0K | $932.0K | $1M | $758.0K | $2M | $2M | $2M | $2M | |
| Current Assets | $218M | $96M | $92M | $34M | $47M | $80M | $124M | $139M | $111M | $149M | $160M | $104M | $143M | $121M | $154M | $155M | |
| PP&E (Net) | $100M | $103M | $105M | $108M | $111M | $104M | $103M | $113M | $109M | $111M | $116M | $112M | $114M | $113M | $109M | $94M | |
| PP&E (Gross) | · | · | $158M | · | · | · | $145M | · | · | · | $149M | · | · | · | $130M | · | |
| Accum. Depreciation | · | · | $53M | · | · | · | $42M | · | · | · | $33M | · | · | · | $20M | · | |
| Intangibles | $421.0K | $494.0K | $578.0K | $653.0K | $742.0K | $773.0K | $821.0K | $951.0K | $969.0K | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| Other Non-current Assets | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $1M | $1M | $1M | $1M | $1M | |
| Total Assets | $396M | $245M | $244M | $189M | $199M | $224M | $270M | $299M | $267M | $309M | $327M | $267M | $310M | $288M | $318M | $301M | |
| Accounts Payable | $12M | $17M | $10M | $22M | $26M | $20M | $24M | $30M | $21M | $21M | $16M | $21M | $28M | $30M | $17M | $22M | |
| Accrued Liabilities | $21M | $25M | $33M | $24M | $15M | $24M | $27M | $19M | $17M | $17M | $43M | $28M | $25M | $31M | $40M | $25M | |
| Short-term Debt | · | $25M | $25M | $74M | · | · | · | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $58M | $176M | $123M | $153M | $53M | $52M | $61M | $59M | $47M | $48M | $67M | $64M | $72M | $81M | $82M | $72M | |
| Capital Leases | $10M | $11M | $11M | $12M | $4M | $4M | $8M | $10M | $11M | $12M | $13M | $14M | $16M | $16M | $17M | $17M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | · | $184.0K | $189.0K | $189.0K | $186.0K | $171.0K | |
| Total Liabilities | $181M | $303M | $250M | $230M | $196M | $191M | $202M | $204M | $187M | $188M | $189M | $175M | $187M | $198M | $200M | $179M | |
| Total Debt | · | $25M | · | $74M | · | · | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | |
| Paid-in Capital | $932M | $820M | $808M | $797M | $791M | $780M | $774M | $763M | $707M | $700M | $694M | $659M | $653M | $587M | $582M | $550M | |
| Retained Earnings | $-702M | $-863M | $-816M | $-831M | $-781M | $-742M | $-702M | $-663M | $-623M | $-575M | $-554M | $-574M | $-530M | $-501M | $-470M | $-443M | |
| Treasury Stock | $18M | $18M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| AOCI | $3M | $3M | $2M | $-6M | $-8M | $-5M | $-4M | $-5M | $-4M | $-3M | $-1M | $7M | $1M | $4M | $6M | $15M | |
| Stockholders' Equity | $216M | $-58M | $-6M | $-41M | $3M | $33M | $68M | $96M | $80M | $122M | $138M | $92M | $124M | $90M | $118M | $123M | |
| Liabilities + Equity | $396M | $245M | $244M | $189M | $199M | $224M | $270M | $299M | $267M | $309M | $327M | $267M | $310M | $288M | $318M | $301M | |
| Shares Outstanding | 94,188,118 | 81,446,126 | 81,120,931 | 80,479,684 | 80,446,284 | 79,418,438 | 78,397,380 | 77,695,418 | 64,684,187 | 64,298,691 | 63,601,015 | 59,597,151 | 59,535,314 | 48,477,209 | 48,477,209 | 44,710,678 |
现金流
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $4M | $3M | $3M | $3M | $2M | $2M | |
| Stock-based Comp | $4M | $4M | $6M | $6M | $6M | $5M | $6M | $6M | $6M | $7M | $7M | $7M | $7M | $6M | $7M | $7M | |
| Other Non-cash | · | $57M | · | · | · | $-5M | · | · | · | $-27M | · | · | · | $-17M | · | · | |
| Operating Cash Flow | $-39M | $18M | $47M | $-12M | $-44M | $-37M | $-23M | $-25M | $-19M | $-37M | $-15M | $-24M | $-29M | $-37M | $-16M | $-21M | |
| CapEx | $332.0K | $2M | $272.0K | $610.0K | $1M | $2M | $1M | $730.0K | $1M | $2M | $3M | $4M | $5M | $9M | $8M | $10M | |
| Investing Cash Flow | $-24M | $-2M | $-1M | $-547.0K | $-761.0K | $-2M | $-1M | $-1M | $-1M | $27M | $51M | $-4M | $-5M | $-9M | $-8M | $-10M | |
| Stock Issued | $114M | $14M | $5M | $0 | $5M | $4M | $4M | $52M | $2M | $2M | $30M | $0 | · | · | · | · | |
| Stock Repurchased | $0 | $18M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | $-4M | · | · | · | $4M | · | · | · | $2M | · | · | · | · | · | · | |
| Financing Cash Flow | $134M | $-10M | $5M | $-219.0K | $5M | $2M | $4M | $50M | $2M | $-1M | $28M | $-404.0K | $58M | $-1M | $25M | $73M | |
| Free Cash Flow | · | $16M | · | · | · | $-39M | · | · | · | $-38M | · | · | · | $-46M | · | · |
盈利能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 76.0% | -13930.7% | · | -11232.0% | -1213.6% | · | · | -367.0% | -16279.8% | -6710.5% | · | -642.0% | -813.1% | -952.6% | · | -473.6% | |
| Net Margin | 50.0% | -15806.5% | · | -12320.2% | -1051.1% | · | · | -360.5% | -17241.1% | -2932.9% | · | -868.1% | -835.6% | -910.7% | · | -774.2% | |
| EBITDA Margin | 76.0% | -12904.1% | · | -10462.4% | -1127.1% | · | · | -367.0% | -16279.8% | -6240.6% | · | -642.0% | -813.1% | -859.9% | · | -473.6% | |
| ROA | 54.0% | -19.8% | · | -20.7% | -16.7% | -15.0% | · | -13.9% | -16.9% | -6.8% | · | -15.6% | -10.5% | -10.5% | · | -12.3% | |
| ROE | 146.9% | 370.1% | · | -183.1% | -93.5% | -51.6% | · | -41.9% | -47.8% | -19.3% | · | -41.3% | -22.3% | -24.1% | · | -24.0% |
流动性与偿付能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.8 | 0.5 | · | 0.2 | 0.9 | 1.5 | · | 2.3 | 2.4 | 3.1 | · | 1.6 | 2.0 | 1.5 | · | 2.1 | |
| Quick Ratio | 2.5 | 0.4 | · | 0.1 | 0.6 | 1.3 | · | 2.1 | 2.2 | 2.7 | · | 1.4 | 1.7 | 0.8 | · | 1.6 | |
| Debt / Equity | · | -0.4 | · | -1.8 | · | · | · | · | · | · | · | · | · | · | · | · | |
| Interest Coverage | 69.7 | -14.3 | · | -15.0 | -14.8 | -13.7 | · | -11.9 | -14.1 | -14.4 | · | -9.7 | -8.6 | -10.4 | · | -12.1 |
效率
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.1 | 0.0 | · | 0.0 | 0.0 | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Receivables Turnover | · | 0.1 | · | 0.1 | 1.9 | · | · | 0.8 | 0.0 | 0.1 | · | 0.5 | 0.2 | · | · | · |
每股
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.29 | $-0.71 | · | $-0.50 | $0.04 | $0.42 | · | $1.23 | $1.24 | $1.89 | · | $1.54 | $2.07 | $1.86 | · | $2.74 | |
| Revenue / Share | $3.43 | $0.00 | · | $0.01 | $0.05 | · | · | $0.15 | $0.00 | $0.01 | · | $0.09 | $0.06 | $0.07 | · | $0.11 | |
| Cash Flow / Share | · | $0.22 | · | · | · | $-0.47 | · | · | · | $-0.57 | · | · | · | $-0.77 | · | · | |
| Cash / Share | $1.52 | $0.88 | · | $0.18 | $0.40 | $0.84 | · | $1.58 | $1.55 | $1.85 | · | $1.06 | $1.56 | $1.42 | · | $2.57 | |
| EPS (TTM) | $0.71 | $-1.48 | · | $-2.10 | $-2.03 | $-2.31 | · | $-1.23 | $-1.42 | $-1.19 | · | $-2.47 | $-2.56 | $-2.79 | · | $-2.50 |
估值 (TTM)
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $398M | $80M | · | $27M | $38M | $35M | · | $14M | $8M | $11M | · | · | · | · | · | $42M | |
| Net Income TTM | $79M | $-121M | · | $-169M | $-158M | $-167M | · | $-88M | $-93M | $-74M | · | $-132M | $-125M | $-129M | · | $-112M | |
| Market Cap | $1.27B | $705M | · | $662M | $525M | $538M | · | $324M | $272M | $390M | · | $293M | $400M | $251M | · | $376M | |
| Enterprise Value | · | $659M | · | $722M | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | 19.0 | -5.9 | · | -3.9 | -3.2 | -2.9 | · | -3.4 | -3.0 | -5.1 | · | -2.0 | -2.6 | -1.9 | · | -3.4 | |
| P/S | 3.2 | 8.8 | · | 24.2 | 13.8 | 15.6 | · | 23.3 | 33.5 | 34.3 | · | · | · | · | · | 8.9 | |
| P/B | 5.9 | -12.1 | · | -16.3 | 177.2 | 16.3 | · | 3.4 | 3.4 | 3.2 | · | 3.2 | 3.2 | 2.8 | · | 3.1 | |
| P / Tangible Book | 5.9 | · | · | · | 236.5 | 16.7 | · | 3.4 | 3.4 | 3.2 | · | 3.2 | 3.3 | 2.8 | · | 3.1 | |
| P / Cash Flow | · | 39.6 | · | · | · | -14.6 | · | · | · | -10.6 | · | · | · | -6.7 | · | · | |
| EV / Revenue | · | 8.3 | · | 26.3 | · | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | 5.3% | -17.1% | · | -25.5% | -31.1% | -34.1% | · | -29.5% | -33.7% | -19.6% | · | -50.3% | -38.1% | -54.0% | · | -29.7% |
最近期在左侧 · 空值显示为 ·
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 收入 | $81M | $33M | $14M | $16M | $38M |
| 营业利润率 % | -130.2% | -493.4% | · | -730.9% | -194.1% |
| 净收入 | $-114M | $-148M | $-84M | $-130M | $-80M |
| 稀释后每股收益 (EPS) | $-1.42 | $-2.12 | $-1.49 | $-2.87 | $-1.80 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 负债/股东权益比率 | -4.3 | · | · | · | · |
| 流动比率 | 0.7 | 2.0 | 2.4 | 1.9 | 2.7 |
| 速动比率 | 0.6 | 1.7 | 2.1 | 1.4 | 2.0 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 自由现金流 | $-50M | $-109M | $-126M | $-118M | $-57M |
机构持有人 (13F) 164 家申报者 · $1.1B 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
持有人
164
持有价值
$1.1B
新仓位
41
已退出持仓
12
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 41 (+19 与上一季度对比) | 12 (-4 与上一季度对比) | 79 (+32 与上一季度对比) | 22 (-18 与上一季度对比) | +11.4M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| Sanofi | $164791427 | 12197737 | 15.52% | 股份 |
| PERCEPTIVE ADVISORS LLC | $145727749 | 10786658 | 13.72% | 股份 |
| Rubric Capital Management LP | $122941000 | 9100000 | 11.58% | 股份 |
| JOHNSON & JOHNSON | $89720775 | 6641064 | 8.45% | 股份 |
| BlackRock, Inc. | $64269475 | 4757178 | 6.05% | 股份 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $59444000 | 4400000 | 5.60% | 股份 |
| Opaleye Management Inc. | $47960500 | 3550000 | 4.52% | 股份 |
| MILLENNIUM MANAGEMENT LLC | $40148370 | 2971752 | 3.78% | 股份 |
| 683 Capital Management, LLC | $31073000 | 2300000 | 2.93% | 股份 |
| Woodline Partners LP | $20266824 | 1500135 | 1.91% | 股份 |
| STATE STREET CORP | $18822429 | 1393222 | 1.77% | 股份 |
| MORGAN STANLEY | $17734617 | 1312703 | 1.67% | 股份 |
| Knoll Capital Management, LLC | $16887500 | 1250000 | 1.59% | 股份 |
| KENNEDY CAPITAL MANAGEMENT LLC | $14934238 | 1105421 | 1.41% | 股份 |
| Long Focus Capital Management, LLC | $14594853 | 1080300 | 1.37% | 股份 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $13714082 | 1015106 | 1.29% | 股份 |
| D. E. Shaw & Co., Inc. | $11522706 | 852902 | 1.08% | 股份 |
| HEIGHTS CAPITAL MANAGEMENT, INC | $11483500 | 850000 | 1.08% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $11471097 | 849082 | 1.08% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $9775336 | 723563 | 0.92% | 股份 |
| CITADEL ADVISORS LLC | $8788106 | 650489 | 0.83% | 股份 |
| Erste Asset Management GmbH | $8667648 | 691200 | 0.82% | 股份 |
| Nuveen, LLC | $8639091 | 639459 | 0.81% | 股份 |
| J. Goldman & Co LP | $8132642 | 601972 | 0.77% | 股份 |
| PFM Health Sciences, LP | $6150914 | 455286 | 0.58% | 股份 |
| NORTHERN TRUST CORP | $5537141 | 409855 | 0.52% | 股份 |
| PANAGORA ASSET MANAGEMENT INC | $4730851 | 350174 | 0.45% | 股份 |
| GOLDMAN SACHS GROUP INC | $4423390 | 327416 | 0.42% | 股份 |
| VANGUARD GROUP INC | $3933287 | 494753 | 0.37% | 股份 |
| BANK OF AMERICA CORP /DE/ | $3914117 | 289720 | 0.37% | 股份 |
| Point72 Asset Management, L.P. | $2734329 | 202393 | 0.26% | 股份 |
| Ghisallo Capital Management LLC | $2702000 | 200000 | 0.25% | 股份 |
| AQR CAPITAL MANAGEMENT LLC | $2655837 | 196583 | 0.25% | 股份 |
| Privium Fund Management B.V. | $2649473 | 196112 | 0.25% | 股份 |
| JPMORGAN CHASE & CO | $2573360 | 205212 | 0.24% | 股份 |
| UBS Group AG | $2493594 | 184574 | 0.23% | 股份 |
| Squarepoint Ops LLC | $2194186 | 162412 | 0.21% | 股份 |
| Y-Intercept (Hong Kong) Ltd | $2000358 | 148065 | 0.19% | 股份 |
| Russell Investments Group, Ltd. | $1990413 | 147329 | 0.19% | 股份 |
| WELLINGTON MANAGEMENT GROUP LLP | $1930890 | 142923 | 0.18% | 股份 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1924283 | 142434 | 0.18% | 股份 |
| Bank of New York Mellon Corp | $1869129 | 138352 | 0.18% | 股份 |
| BLAIR WILLIAM & CO/IL | $1695208 | 125478 | 0.16% | 股份 |
| Voleon Capital Management LP | $1591343 | 117790 | 0.15% | 股份 |
| Swiss National Bank | $1505014 | 111400 | 0.14% | 股份 |
| BARCLAYS PLC | $1336882 | 98955 | 0.13% | 股份 |
| Invesco Ltd. | $1277235 | 94540 | 0.12% | 股份 |
| ALPS ADVISORS INC | $1258943 | 93186 | 0.12% | 股份 |
| Prosight Management, LP | $1215900 | 90000 | 0.11% | 股份 |
| Aquatic Capital Management LLC | $1176235 | 87064 | 0.11% | 股份 |
激进投资者及 5%+ 股东 1 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| Perceptive Advisors LLC, Joseph Edelman, Perceptive Life Sciences Master Fund, Ltd. ×9 申报 | 2026年4月24日 | 12.60% | 修订 | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
公司内部人士 19 位内幕人士 · 8 位高管 · 11 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Alexandria Forbes | PRESIDENT & CEO | 2026年8月18日 S | 1325695 | 0 | 4 | $-2285805 |
| Richard Giroux | CFO & COO | 2026年7月21日 S | 908530 | 0 | 3 | $-1485760 |
| Katherine Breedis | Chief Financial Officer | 2018年12月29日 A | · | 0 | 0 | $0 |
| Stuart Naylor | CHIEF SCI OFCR, OPHTHALMOLOGY | 2026年7月7日 S | 640846 | 0 | 3 | $-668377 |
| Robert J Wollin | GENERAL COUNSEL AND SECRETARY | 2026年6月25日 A | 57377 | 0 | 0 | $0 |
| Robert K Zeldin | CHIEF MEDICAL OFFICER | 2026年6月25日 A | 146204 | 0 | 0 | $0 |
| Penny Renee Fleck | CHIEF DEVELOPMENT OFFICER | 2026年5月13日 A | · | 0 | 0 | $0 |
| Bruce Gottlieb | General Counsel | 2019年4月1日 A | · | 0 | 0 | $0 |
| Alan Sebulsky | 董事 | 2026年9月23日 A | · | 0 | 0 | $0 |
| Debra Yu | 董事 | 2026年6月11日 A | · | 0 | 0 | $0 |
| Ellen Hukkelhoven | 董事 | 2026年6月11日 A | · | 0 | 0 | $0 |
| Keith R. Harris | 董事 | 2026年6月11日 A | 200000 | 0 | 0 | $0 |
| Neil Mendoza | 董事 | 2026年6月11日 A | · | 0 | 0 | $0 |
| Nicole Seligman | 董事 | 2026年6月11日 A | 5000 | 0 | 0 | $0 |
| Thomas E Shenk | 董事 | 2026年6月11日 A | 157476 | 0 | 0 | $0 |
| Martin Indyk | 董事 | 2024年6月6日 A | 35000 | 0 | 0 | $0 |
| Joel S Marcus | 董事 | 2022年6月7日 A | 12882 | 0 | 0 | $0 |
| Arnold J Levine | 董事 | 2022年6月7日 A | · | 0 | 0 | $0 |
| Johnson & Johnson Innovation - JJDC, Inc. | 10% 所有者 | 2023年9月15日 J | 0 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
ETF持仓 由 18 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| IWC · iShares Trust | 0.18% | 204089 SH | 2026年9月11日 | 每日 |
| ESSC · Strategy Shares | 0.12% | 3786 NS | 2026年7月31日 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trus... | 0.07% | 6788 SH | 2026年10月1日 | 每日 |
| IBB · iShares Trust | 0.07% | 535017 SH | 2026年9月11日 | 每日 |
| IWO · iShares Trust | 0.04% | 447107 SH | 2026年9月11日 | 每日 |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.04% | 51041 SH | 2026年8月19日 | 每日 |
| IWM · iShares Trust | 0.03% | 1527344 SH | 2026年9月11日 | 每日 |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.02% | 57098 SH | 2026年10月1日 | 每日 |
| RSSL · Global X Funds | 0.02% | 28718 NS | 2026年7月31日 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.02% | 345700 SH | 2026年8月19日 | 每日 |
| ISCG · iShares Trust | 0.02% | 12900 SH | 2026年9月11日 | 每日 |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.01% | 11041 SH | 2026年8月19日 | 每日 |
| VHT · VANGUARD WORLD FUND | 0.01% | 167269 SH | 2026年8月19日 | 每日 |
| WSML · iShares Trust | 0.01% | 3440 SH | 2026年9月11日 | 每日 |
| IWV · iShares Trust | 0.00% | 17625 SH | 2026年9月11日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 5601 SH | 2026年8月19日 | 每日 |
| IWN · iShares Trust | · | 113658 SH | 2026年9月11日 | 每日 |
| ISCB · iShares Trust | · | 1898 SH | 2026年9月11日 | 每日 |
MGTX 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
评级 · 13 位分析师
买入
中位数目标
$23.50
+117.8%
4 30.8%
强烈买入
8 61.5%
买入
1 7.7%
持有
0 0.0%
卖出
0 0.0%
强烈卖出
12个月价格目标
8 位分析师 · 2026-10-03平均目标 $27.75 +157.2%
← 低于所有目标
当前价格 $10.79
最低$16.00
平均值$27.75
最高$50.00
同行比较（GICS 子行业） 关键指标与行业同行对比
财年依据，价格截至各公司上一个财年末收盘价。
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| MGTX | $645M | -5.6 | 144.6% | -140.3% | 8062.2% | · |
| MNKD | $1.75B | 283.5 | 22.2% | 1.7% | -11.1% | · |
| BCAX | $953M | -6.7 | · | · | -33.0% | · |
| TRAX | · | · | · | · | · | · |
| VOR | $506M | -0.2 | · | · | 83.4% | · |
| JANX | $833M | -7.5 | -5.5% | -1136.2% | -11.7% | · |
| AKTS | · | · | · | · | · | · |
| ODTX | · | · | · | · | · | · |
| SVRA | $1.23B | -11.4 | · | · | -73.4% | · |
| KURA | $913M | -3.3 | 25.2% | -413.0% | -116.2% | · |
我的指标 您的个人关注列表 — 来自完整基本面的选定行
选择对您重要的指标 — 点击上方完整基本面中任意行的 + 号。
您的选择已保存，并会跟随您浏览所有股票。
来源：SEC 10-Q 于 八月 13, 2026 申报